Literature DB >> 23597717

Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?

Michael M McNeil1, Rongxia Li, Susanne Pickering, Theresa M Real, Philip J Smith, Michael R Pemberton.   

Abstract

BACKGROUND: Healthcare provider (HCP) reporting to the Vaccine Adverse Event Reporting System (VAERS) is important to assuring the safety of U.S. licensed vaccines. HCP awareness of and practices regarding reporting of adverse events following immunization (AEFI) is understudied.
METHODS: A large, nationally representative sample of U.S. office-based HCP across three occupational groups (physicians, mid-level providers [physician assistants, advanced practice nurses] and nurses) and three primary care practice areas (pediatrics, family medicine, internal medicine) were surveyed utilizing standardized methodology. We assessed HCP familiarity with VAERS, the situations under which they were likely to report an AEFI, and the methods they used and preferred for reporting. We used logistic regression to determine factors associated with HCP not reporting AEFI to VAERS.
RESULTS: Our survey response rate was 54.9%. The percentage of HCP aware of VAERS (71%) varied by occupation and primary care practice area. About 37% of HCP had identified at least one AEFI with only 17% of these indicating that they had ever reported to VAERS. More serious events were more likely to be reported. Factors associated with HCP not reporting AEFI included: HCP not familiar versus very familiar with filing a paper VAERS report (OR=12.84; p<0.0001), primary care practice area of internal medicine versus pediatrics (OR=4.22; p=0.0005), and HCP not familiar versus very familiar with when it was required to file a VAERS report (OR=5.52; p=0.0013).
CONCLUSIONS: Specific educational interventions targeted to HCP likely to see AEFI but not currently reporting may improve vaccine safety reporting practices. Published by Elsevier Ltd.

Mesh:

Substances:

Year:  2013        PMID: 23597717     DOI: 10.1016/j.vaccine.2013.04.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies.

Authors:  Jerome Ateudjieu; Beat Stoll; Anne Cecile Bisseck; Ayok M Tembei; Blaise Genton
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

2.  Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Authors:  Hazel J Clothier; Nigel W Crawford; Melissa Russell; Heath Kelly; Jim P Buttery
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

3.  Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.

Authors:  Adriana Parrella; Michael Gold; Annette Braunack-Mayer; Peter Baghurst; Helen Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

4.  Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Authors:  Susann Muehlhans; Max von Kleist; Tatiana Gretchukha; Martin Terhardt; Ulrich Fegeler; Wolfgang Maurer; Leila Namazova-Baranova; Gerhard Gaedicke; Alexander Baranov; Barbara Rath
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

5.  Assessing the Quality of SK&A's Office-Based Physician Database for Identifying Oncologists.

Authors:  Samuel Valdez; Mireille Jacobson
Journal:  Med Care Res Rev       Date:  2021-05-24       Impact factor: 2.971

6.  Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania.

Authors:  Irsida Mehmeti; Erida Nelaj; Artan Simaku; Eugena Tomini; Silva Bino
Journal:  Heliyon       Date:  2017-06-20

7.  Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya.

Authors:  Calistus Wanjala Masika; Harrysone Atieli; Tom Were
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

8.  Active surveillance study of adverse events following immunisation of children in the Czech Republic.

Authors:  Jana Danova; Aneta Kocourkova; Alexander M Celko
Journal:  BMC Public Health       Date:  2017-02-06       Impact factor: 3.295

9.  Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Authors:  Adriana Parrella; Annette Braunack-Mayer; Michael Gold; Helen Marshall; Peter Baghurst
Journal:  BMC Health Serv Res       Date:  2013-08-15       Impact factor: 2.655

10.  Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems.

Authors:  Paolo Pellegrino; Carla Carnovale; Valentina Perrone; Marco Pozzi; Stefania Antoniazzi; Emilio Clementi; Sonia Radice
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.